Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DMD Heart Protection Study
2007-005932-10Phase 3Completed
- Sponsor
- Newcastle Hospitals NHS Foundation Trust
- Start
- Apr 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in Duchenne muscular dystrophy (DMD) comparing Perindopril + bisoprolol with Placebo (2 arms). Primary endpoints: Supportive cardiac imaging endpoint and Supportive diastolic function endpoint. Started Apr 2009; status: completed.
02
Drugs
perindoprilbisoprolol
03
Conditions
Duchenne muscular dystrophy (DMD)
Beyond the preview
Go deeper on 2007-005932-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005932-10.